LDC1267
CAS No. 1361030-48-9
LDC1267 ( LDC1267; LDC-1267; LDC 1267 )
产品货号. M17256 CAS No. 1361030-48-9
LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥356 | 有现货 |
|
5MG | ¥567 | 有现货 |
|
10MG | ¥867 | 有现货 |
|
25MG | ¥1434 | 有现货 |
|
50MG | ¥2114 | 有现货 |
|
100MG | ¥3572 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称LDC1267
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).
-
产品描述LDC1267 is a potent and selective TAM kinase inhibitor. LDC1267 displays lower activity against Met, Aurora B, Lck, Src, and CDK8. LDC1267 markedly reduced murine mammary cancer and melanoma metastases dependent on NK cells. The TAM tyrosine kinase receptors Tyro3, Axl and Mer (also known as Mertk) were identified as ubiquitylation substrates for Cbl-b. Treatment of wild-type NK cells with a newly developed small molecule TAM kinase inhibitor conferred therapeutic potential, efficiently enhancing anti-metastatic NK cell activity in vivo.
-
同义词LDC1267; LDC-1267; LDC 1267
-
通路Cell Cycle/DNA Damage
-
靶点PLK
-
受体AXL; Mer; Tyro3
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number1361030-48-9
-
分子量560.55
-
分子式C30H26F2N4O5
-
纯度98%
-
溶解度DMSO : 50 mg/mL. 89.20 mM; H2O : < 0.1 mg/mL
-
SMILESc1(c(cc2c(c1)c(ccn2)Oc1ccc(cc1F)NC(=O)c1nn(cc1OCC)c1ccc(cc1C)F)OC)OC
-
化学全称N-[4-[(6,7-dimethoxy-4-quinolyl)oxy]-3-fluoro-phenyl]-4-ethoxy-1-(4-fluoro-2-methyl-phenyl)pyrazole-3-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Paolino M, et al. Nature. 2014, 507(7493), 508-512.
产品手册
关联产品
-
RO 3280
RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1)
-
Rigosertib sodium
Rigosertib sodium (ON 01910.Na) is a potent, non-ATP-competitive PLK1 inhibitor (IC50=9-10 nM).
-
GW843682X
GW843682X is a selective, ATP-competitive inhibitor of PLK1 and PLK3, with IC50s of 2.2 nM and 9.1 nM, respectively, and is also >100-fold selective against ~30 other kinases.